Zydus Receives Approval for Isotretinoin Capsules

  Published 1 year ago

Zydus Lifesciences received US approval for its generic Isotretinoin capsules, a treatment for severe acne similar to Absorica. The US market reached $115.4M in sales (MAT 2025), marking Zydus's 427th approval.

  • Generic equivalent of Absorica capsules.
  • Treats severe nodular acne.
  • $115.4M US annual sales (2025).

You might like these

Responsible AI in India's Finance: A Roadmap

Stock Ratings Roundup: Analyst Updates

J&K Bank Q1 Profit Rises 7% YoY

Nestle India Bonus Issue Adjusts Price

City Union Bank Gains on Strong Q1 Show

Glenmark Launches TEVIMBRA in India for Lung & Esophageal Cancers

GFL Q1 Profit Jumps 66% YoY

News that matters the most ⚡